Major Surgical or Invasive Procedure: paracentesis x 3 PICC line placement   History of Present Illness: Mr. [**Known lastname 916**] is a 63 yo, M, with hx of IgA deficiency, Crohn's disease, liver disease w/ nodular regenerative hyperplasia, COPD and hx of heavy smoking and ETOH consumption who was admitted to [**Hospital1 18**] on [**2134-5-20**] w/ complaints of Severe Abdominal Pain, the patient describes that he felt a sudden onset severe abdominal pain, described as sharp and "like someone was twisting my intestine", [**11-9**] on pain scale, he describes it as generalized abdominal pain w/ no radiation to the back or any other areas, denies precipating factors and the pain was exacerbated by movement.
He underwent #2 Abdominal taps in the past month, the first one was perfomed on [**2134-5-10**] and was reported positive for Malignancy.
- IgA deficiency, gets monthly IVIG - Iron deficiency anemia- monthly IV Fe - Liver Disease- HCV (-) [**4-2**], HBsAb (+) HBsAg,cAb,IgMHBc (-) [**4-2**] -Nodular regenerative hyperplasia on biopsy is associated with other clinical conditions such as Felty's syndrome or other immunologically mediated disease such as SLE, sarcoidosis, polymyalgia rheumatica, primary biliary cirrhosis, primary sclerosing cholangitis -C/b development of ascites, splenomegaly - S/p mitral valve repair for MVP in '[**31**] - COPD - Hypothyroidism - H/o prostate cancer in-situ - H/o chronic prostatitis - H/o empyema - Bronchiectasis - PCP [**Name Initial (PRE) 11091**] [**4-5**] (HIV test negative at that time) - GERD - HTN - h/o duodenitis   Social History: Works as accountant, currently downsizing business.
Physical Exam: VS: Afebrile 95 111/58 29 O2 sat 98% RA Gen: cachectic, NAD HEENT: PERRL, EOMI, clear OP, dry, anicteric Neck: supple, JVD to lower ear lobe Lungs: dull at bases b/l, crackles [**2-1**] way up back Heart: RRR +S1/S2 no m/r/g Abd: Distended, + surgical mid abd scar, + ventral hernia(reducible) w/slight erythema/warmth, + fluid wave, tender to light palpation diffusely however no rebound/guarding, + BS, + splenomegaly Ext: 3+ pitting edema from ankle Neuro: A&O, No focal deficits   Pertinent Results: [**2134-5-20**] 06:57PM BLOOD WBC-13.7*# RBC-5.81# Hgb-16.7# Hct-49.1 MCV-85 MCH-28.8 MCHC-34.1 RDW-17.9* Plt Ct-263 [**2134-5-29**] 05:23AM BLOOD WBC-11.0 RBC-4.87 Hgb-13.9* Hct-41.6 MCV-85 MCH-28.6 MCHC-33.5 RDW-17.9* Plt Ct-269# [**2134-5-20**] 06:57PM BLOOD Neuts-77* Bands-12* Lymphs-8* Monos-1* Eos-0 Baso-0 Atyps-2* Metas-0 Myelos-0 [**2134-5-23**] 04:10AM BLOOD Neuts-82* Bands-13* Lymphs-2* Monos-3 Eos-0 Baso-0 Atyps-0 Metas-0 Myelos-0 [**2134-5-20**] 06:57PM BLOOD Hypochr-NORMAL Anisocy-1+ Poiklo-NORMAL Macrocy-NORMAL Microcy-1+ Polychr-NORMAL [**2134-5-23**] 04:10AM BLOOD Hypochr-2+ Anisocy-2+ Poiklo-2+ Macrocy-2+ Microcy-2+ Polychr-OCCASIONAL Ovalocy-1+ Burr-2+ Pencil-OCCASIONAL Tear Dr[**Last Name (STitle) 833**] [**Name (STitle) 4486**] [**2134-5-20**] 06:57PM BLOOD PT-12.6 PTT-22.9 INR(PT)-1.1 [**2134-5-21**] 09:10AM BLOOD PT-17.1* PTT-34.7 INR(PT)-1.6* [**2134-5-28**] 05:41AM BLOOD PT-14.7* PTT-24.4 INR(PT)-1.3* [**2134-5-29**] 05:23AM BLOOD Plt Ct-269# [**2134-5-23**] 04:10AM BLOOD Ret Aut-1.6 [**2134-5-22**] 03:47AM BLOOD Fibrino-443* [**2134-5-20**] 06:57PM BLOOD Glucose-90 UreaN-23* Creat-1.3* Na-136 K-4.7 Cl-97 HCO3-23 AnGap-21 [**2134-5-29**] 05:23AM BLOOD Glucose-101 UreaN-15 Creat-0.6 Na-140 K-4.2 Cl-107 [**2134-5-20**] 06:57PM BLOOD ALT-38 AST-54* LD(LDH)-207 AlkPhos-427* Amylase-36 TotBili-1.0 [**2134-5-28**] 05:41AM BLOOD ALT-9 AST-12 AlkPhos-183* TotBili-0.8 [**2134-5-20**] 06:57PM BLOOD Lipase-12 [**2134-5-22**] 03:47AM BLOOD Lipase-7 [**2134-5-24**] 06:15AM BLOOD Lipase-21 [**2134-5-21**] 09:10AM BLOOD cTropnT-<0.01 [**2134-5-20**] 06:57PM BLOOD Albumin-3.1* Calcium-7.8* Phos-5.7*# Mg-1.5* [**2134-5-24**] 06:15AM BLOOD Albumin-4.0 Calcium-8.9 Phos-2.0* Mg-2.0 [**2134-5-27**] 05:15AM BLOOD Mg-1.6 [**2134-5-23**] 07:50AM BLOOD PSA-0.8 [**2134-5-23**] 04:10AM BLOOD Hapto-232* [**2134-5-20**] 07:00PM BLOOD Lactate-3.7* [**2134-5-20**] 09:28PM BLOOD Lactate-2.5* .
Peritoneal Fluid [**2134-5-23**] WBC [**Numeric Identifier **] RBC 8000 Poly 89 Band 0 Lymph 4 Mono 7 Macro 0 Other 0 TP 1.9 gluc 174 LDH 733 alb 1.3 .
Peritoneal Fluid [**2134-5-24**] WBC [**Numeric Identifier 11094**] RBC 7425 Poly 97 Band 1 Lymph 1 Mono 1 Macro 0 Other 0 TP 2.1 gluc 115 alb 1.4 .
Screen predicts NO synergy with penicillins or          vancomycin.
Consult ID for treatment options.
IMPRESSION: 1) New consolidation in the medial aspect of the right lower lung zone, concerning for pneumonia.
Optimal evaluation of the visceral organs is limited secondary to lack of intravenous contrast.
CT PELVIS WITH WITHOUT CONTRAST: Foley catheter is seen in a partially distended bladder.
OR THERAPEUTIC  [**2134-5-24**] 3:05 PM PROCEDURE: The risks and benefits of the procedure were explained to the patient and written informed consent was obtained.
Local anesthesia was achieved via injection of 5 cc of 1% lidocaine with bicarbonate.
The patient tolerated the procedure well, with no complications evident at the time of the procedure.
IMPRESSION: Successful ultrasound-guided diagnostic and therapeutic paracentesis.
CT ABD&PELVIS W/O C COLON TECHNIQUE  [**2134-5-25**] 5:24 PM ABDOMEN CT WITHOUT AND WITH INTRAVENOUS CONTRAST: The hazy opacity with septal thickening and interstitial disease in the right middle lobe has decreased since [**2134-5-21**], likely reflecting resolving pneumonia and atelectasis.
Rectal tube is in place.
Scrotal calcifications bilaterally are of uncertain etiology.
Ultrasound could be performed as clinically indicated.
GUIDANCE FOR [**Female First Name (un) **]/ABD/PARA CENTESIS US  [**2134-5-27**] 2:18 PM PROCEDURE: The risks and benefits of the procedure were explained to the patient, and written informed consent was obtained.
Local anesthesia was achieved via injection of 4 cc of 1% lidocaine with bicarbonate.
The patient tolerated the procedure well, without complications evident at the time of the procedure.
Patient had three large volume paracentesis (see results section) during this admission.
Fluid cytology c/w adeno CA of unclear primary and SBP growing [**Name (NI) **] and Veillonella species.
He likely needs ongoing therapeutic paracentesis on an ongoing basis.
He was discharged on Cefepime, Linezolid and Flagyl after PICC was placed for home access.
He was also treated with Ursodiol, Aldactone and lasix to manage his ascites.
Veillonella can be a mouth flora often confused with meningococcus, of questionable virulence.
He as treated with broad coverage including Linezolid for [**Last Name (NamePattern1) **], Cefepime and Flagyl.
He was discharged with a PICC for ongoing antibiotic treatment with scheduled follow up with ID.
Patient is on chronic steroids and PCP [**Name Initial (PRE) **].
Patient was treated with high dose steroids given his acute infection with Hydrocortisone 100 mg q 8 hrs x 3 doses.
He was then continued on Prednisone.
He was continued on Albuterol/Atrovent nebs.
Prednisone 10 mg Tablet Tablet PO DAILY 2.
Ursodiol 300 mg PO BID 3.
Albuterol 90 mcg/Actuation Aerosol Sig: 1-2 Puffs Inhalation  Q6H (every 6 hours) as needed.
Levothyroxine 25 mcg po QD 5.
Lorazepam 0.5 mg PO QHS PRN 6.
Trimethoprim-Sulfamethoxazole 160-800 mg PO QD 7.
Spironolactone 50 mg po QD 8.
Furosemide 40 mg po QD 9.
Prilosec 20 mg Po QD   Discharge Medications: 1.
Ursodiol 300 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
Levothyroxine 25 mcg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Trimethoprim-Sulfamethoxazole 80-400 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Prednisone 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Acetaminophen 325 mg Tablet Sig: One (1) Tablet PO Q4-6H (every 4 to 6 hours) as needed.
Linezolid 600 mg Tablet Sig: One (1) Tablet PO Q12H (every 12 hours) for 2 weeks.
Spironolactone 100 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Morphine 15 mg Tablet Sustained Release Sig: One (1) Tablet Sustained Release PO Q12H (every 12 hours).
Heparin Flush PICC (100 units/ml) 2 ml IV DAILY:PRN 10 ml NS followed by 2 ml of 100 Units/ml heparin (200 units heparin) each lumen Daily and PRN.
Sodium Chloride 0.9%  Flush 3 ml IV DAILY:PRN Peripheral IV - Inspect site every shift 11.
Pantoprazole 40 mg Tablet, Delayed Release (E.C.)
Cefepime 2 g Piggyback Sig: Two (2) g Intravenous  every eight (8) hours for 2 weeks.
Metronidazole 500 mg Tablet Sig: One (1) Tablet PO every eight (8) hours for 2 weeks.
Morphine 10 mg/5 mL Solution Sig: 5-10 mg PO Q4-6H (every 4 to 6 hours) as needed.
Albuterol 90 mcg/Actuation Aerosol Sig: Two (2) puffs Inhalation every 4-6 hours as needed for shortness of breath or wheezing.
Ipratropium Bromide 17 mcg/Actuation Aerosol Sig: Two (2) puffs Inhalation every six (6) hours as needed for shortness of breath or wheezing.
Levofloxacin 500 mg Tablet Sig: One (1) Tablet PO once a day: start after taking Cefepime for 2 weeks.
SECONDARY: - IgA deficiency, gets monthly IVIG - Iron deficiency anemia- monthly IV Fe - Liver Disease- HCV(-)[**4-2**],HBsAb (+),HBsAg,cAb,IgMHBc(-)[**4-2**] - mitral valve repair for MVP in '[**31**] - Hypothyroidism - GERD - HTN - COPD   Discharge Condition: stable   Discharge Instructions: --seek immediate medical attention if experiencing fever, chills, or any concerning symptoms --return to [**Hospital Ward Name **] 8 for paracentesis if ascites becomes uncomfortable --take all medications as prescribed   Followup Instructions: Provider: [**Name10 (NameIs) 5085**] [**Name11 (NameIs) **],BEC [**Hospital **] [**Hospital 11099**] CLINIC Date/Time:[**2134-7-1**] 9:00 .
